Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients
Fact sheetPublished 25/11/06Open the original
Summary
President Trump announces most-favored-nation pricing agreements with Eli Lilly and Novo Nordisk: Ozempic and Wegovy fall from $1,000 and $1,350 a month to $350 on TrumpRx, the Medicare price is $245, and Medicare beneficiaries pay a $50 monthly co-pay.
By industry
- Healthcare & Drug Pricing1 trading day+1.2%p15 stocks5 trading days+3.6%p15 stocks20 trading days+3.5%p15 stocks
“unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/11/05 | 0.0% | 0.0% |
| 25/11/06 | +0.3% | −0.9% |
| 25/11/07 | +0.5% | −0.9% |
| 25/11/10 | +0.5% | +0.5% |
| 25/11/11 | +3.3% | +0.8% |
| 25/11/12 | +4.4% | +0.8% |
| 25/11/13 | +4.5% | −0.8% |
| 25/11/14 | +3.5% | −0.8% |
| 25/11/17 | +4.1% | −1.8% |
| 25/11/18 | +4.5% | −2.7% |
| 25/11/19 | +3.8% | −1.7% |
| 25/11/20 | +3.2% | −3.8% |
| 25/11/21 | +5.1% | −2.7% |
| 25/11/24 | +5.5% | −1.2% |
| 25/11/25 | +7.7% | −0.4% |
| 25/11/26 | +7.7% | +0.3% |
| 25/11/28 | +7.3% | +0.8% |
| 25/12/01 | +5.5% | +0.3% |
| 25/12/02 | +4.5% | +0.6% |
| 25/12/03 | +4.8% | +0.9% |
| 25/12/04 | +4.4% | +1.0% |
Stocks it names
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- David Cordani
BuyCigna Group
BuyCigna Group
CI
$999.9K
4,134 sh
$999.9K
Filed 25/11/03
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$128.2M
120,016 sh
$128.2M
Filed 25/11/25
Traded 25/11/24
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$101.4M
96,516 sh
$101.4M
Filed 25/11/20
Traded 25/11/19
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$107M
103,871 sh
$107M
Filed 25/11/17
Traded 25/11/14
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$57.7B
55,908 sh
$57.7B
Filed 25/11/17
Traded 25/11/14
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$18.1B
17,567 sh
$18.1B
Filed 25/11/17
Traded 25/11/14
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$170.6M
197,814 sh
$170.6M
Filed 25/11/03
Traded 25/10/31
- John G. Morikis
BuyJohnson & Johnson
BuyJohnson & Johnson
JNJ
$257.7K
1,250 sh
$257.7K
Filed 25/12/01
Traded 25/11/26
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$47.9M
47,073 sh
$47.9M
Filed 25/11/13
Traded 25/11/12
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$46.8M
54,191 sh
$46.8M
Filed 25/11/03
Traded 25/10/31
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$46.6M
45,246 sh
$46.6M
Filed 25/11/14
Traded 25/11/13
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$32.8M
33,154 sh
$32.8M
Filed 25/11/12
Traded 25/11/11
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.7M
36,114 sh
$30.7M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.2M
28,768 sh
$30.2M
Filed 25/11/20
Traded 25/11/19
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.2M
30,633 sh
$30.2M
Filed 25/11/12
Traded 25/11/11
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$28.7M
31,016 sh
$28.7M
Filed 25/11/06
Traded 25/11/05
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.6M
29,709 sh
$26.6M
Filed 25/11/04
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.5M
26,761 sh
$26.5M
Filed 25/11/12
Traded 25/11/11
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$25.3M
23,916 sh
$25.3M
Filed 25/11/24
Traded 25/11/21
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$24M
23,863 sh
$24M
Filed 25/11/13
Traded 25/11/12